INC Inks Clinical Development VP

James Taylor has been appointed vice president of Clinical Development at INC Research. Mr. Taylor will serve as the primary liaison to biopharma customers, vendors and investigative sites for the company’s General Medicine Business Unit. Mr. Taylor joins the company from Pfizer, where he most recently served as vice president of Global Clinical Trial management.
 
Mr. Taylor has more than 25 years of experience in the life sciences industry, including 15 years overseeing and executing global clinical trials. He also brings expertise in CRO selection and start-up, investigative site performance and contracting, CRO oversight and risk management, and alliance management. Mr. Taylor has experience serving as global head of outsourcing management at Sanofi-Aventis, where he was responsible for driving the global outsourcing strategy for its drug innovation and approval business unit.
 
“Jim is an accomplished leader with global experience across all phases of complex enterprise operations involving the execution of clinical trials,” said Jamie Macdonald, chief executive officer, INC Research. “Having worked in large pharma for many years, he brings a strong customer perspective, which allows him to anticipate our customers’ needs and communicate their requirements more effectively. This insight, along with his unique blend of business and operational expertise, will be instrumental in further strengthening our relationships to drive innovation and accelerate decision making in clinical programs.”